NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Jaan Biotherapeutics

Jaan Biotherapeutics

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://jaanbio.com/

Last Round

Accelerator

Dec 11, 2025

Total Funding Raised

$3.44M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Jaan Biotherapeutics is a biotechnology company that develops novel therapies intended for regenerating damaged heart tissue in patients with cardiovascular disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B2C

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

cardiac regenerationgene therapyAAV gene therapyRNA therapyIschemic Heart DiseasemicroRNA therapyIHDregenerative medicineheart attack therapypreclinical biotechcardiomyopathy therapyoligonucleotide therapydrug discoveryhypertrophic cardiomyopathyHCMDuchenne Muscular DystrophyDMD

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Jaan Biotherapeutics Comps

Public and private peers based on sector, stage, and business model.

Jaan Biotherapeutics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Jaan Biotherapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorDec 11, 2025
GrantOct 6, 2025
GrantSep 8, 2020
GrantMar 16, 2017

Jaan Biotherapeutics Investors

Notable investors and investment history

Jaan Biotherapeutics investors
InvestorRounds
NIH RADxGrant
National Heart, Lung, and Blood InstituteGrant
Charles River Incubator ProgramAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 11, 2025

    Received funding from Charles River Incubator Program.

  • Nov 9, 2025

    Monthly visitors grew 100% MoM, reaching 2.9K.

Jaan Biotherapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Jaan Biotherapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Jaan Biotherapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range2
Year Founded2015
Last FundingDec 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.